cv 3988 has been researched along with deferoxamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jamieson, WR; Poostizadeh, A; Qayumi, AK | 1 |
1 other study(ies) available for cv 3988 and deferoxamine
| Article | Year |
|---|---|
Effects of platelet-activating factor antagonist CV-3988 in preservation of heart and lung for transplantation.
Topics: Animals; Carbon Dioxide; Deferoxamine; Extravascular Lung Water; Female; Heart-Lung Transplantation; Hemodynamics; Organ Preservation; Oxygen; Phospholipid Ethers; Platelet Activating Factor; Respiration; Swine | 1991 |